CYBERNANO
Desconocido
EXPERT: EXpanding Platforms for Efficacious mRNA Therapeutics
CYBERNANO
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The overall objective of EXPERT is to create an off-the-shelf mRNA-delivering nanomedicine platform that is manufactured via a quality-by-de...
2019-07-03 - 2025-02-28 | Financiado
2019-07-03 - 2025-02-28 | Financiado
TBMED: A testing bed for the development of high risk medical devices
CYBERNANO
participó en un
H2020:
H2020-NMBP-TO-IND-2018-2020
TBMED will establish an open innovation testing bed specialized in the development of high-risk devices (≥Class IIb). Due to a long reimburs...
2018-12-12 - 2023-08-31 | Financiado
2018-12-12 - 2023-08-31 | Financiado
* No se disponen de datos de la empresa actual.